Michael Flax
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Michael Flax is currently Chairman, Chief Executive & Financial Officer at Nutra Pharma Corp.
since 2024 and a Member of the American Association of Endodontists.
Formerly, Dr. Flax was Director at Nutra Pharma Corp.
from 2002 to 2005.
Education includes an undergraduate degree from Miami University, a graduate degree from St. John's University conferred in 1977, and a doctorate from Georgetown University conferred in 1981.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-05-2026 | 343 ( 0% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUTRA PHARMA CORP. | Algemeen Directeur | 20-03-2024 |
American Association of Endodontists | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| NUTRA PHARMA CORP. | Algemeen Directeur | 01-06-2005 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Nutra Pharma Corp.
Nutra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treat pain, autoimmune disorders, viral diseases | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association of Endodontists |
Kies jouw editie
Alle financiële informatie op nationaal niveau